Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SWEMAC OSMEDIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   4.1% 2.2% 3.2% 2.9% 2.3% 1.9% 14.7% 14.5%   Credit score (0-100)   51 68 56 57 64 69 14 15   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.5 0.0 0.0 0.2 3.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   17,626 15,870 19,395 19,058 16,517 14,779 0.0 0.0   EBITDA   9,093 7,651 11,233 10,826 8,238 6,862 0.0 0.0   EBIT   8,898 7,249 10,812 10,483 7,913 6,422 0.0 0.0   Pre-tax profit (PTP)   8,853.7 7,120.4 10,747.7 10,401.5 7,768.3 6,319.6 0.0 0.0   Net earnings   6,901.6 5,522.0 8,305.4 8,108.3 6,042.4 4,921.4 0.0 0.0   Pre-tax profit without non-rec. items   8,854 7,120 10,748 10,401 7,768 6,320 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   411 1,454 1,099 739 591 1,250 0.0 0.0   Shareholders equity total   7,192 5,813 8,596 8,399 6,333 5,212 0.0 0.0   Interest-bearing liabilities   826 4,902 0.0 2,305 3,108 6,042 0.0 0.0   Balance sheet total (assets)   13,935 17,051 20,593 18,635 15,496 17,131 0.0 0.0   Net Debt   -150 3,529 -6,951 -1,757 1,991 4,609 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   17,626 15,870 19,395 19,058 16,517 14,779 0.0 0.0   Gross profit growth   -3.8% -10.0% 22.2% -1.7% -13.3% -10.5% -100.0% 0.0%   Employees   9 9 9 9 9 9 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   13,935 17,051 20,593 18,635 15,496 17,131 0 0   Balance sheet change%   -5.3% 22.4% 20.8% -9.5% -16.8% 10.6% -100.0% 0.0%   Added value   9,092.5 7,650.6 11,232.7 10,825.8 8,256.0 6,862.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -260 642 -775 -703 -473 219 -1,250 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   50.5% 45.7% 55.7% 55.0% 47.9% 43.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   62.1% 46.8% 57.5% 53.4% 46.4% 39.4% 0.0% 0.0%   ROI %   110.3% 76.2% 107.0% 103.2% 75.9% 60.6% 0.0% 0.0%   ROE %   90.4% 84.9% 115.3% 95.4% 82.0% 85.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.6% 34.1% 41.7% 45.1% 40.9% 30.4% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1.7% 46.1% -61.9% -16.2% 24.2% 67.2% 0.0% 0.0%   Gearing %   11.5% 84.3% 0.0% 27.4% 49.1% 115.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.1% 4.5% 2.8% 7.1% 5.4% 2.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.6 1.0 0.9 0.8 0.6 0.0 0.0   Current Ratio   2.0 1.4 1.7 1.8 1.7 1.4 0.0 0.0   Cash and cash equivalent   976.1 1,372.6 6,950.8 4,062.7 1,117.7 1,433.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   6,781.3 4,653.4 8,105.0 8,071.9 6,044.4 4,160.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,010 850 1,248 1,203 917 762 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,010 850 1,248 1,203 915 762 0 0   EBIT / employee   989 805 1,201 1,165 879 714 0 0   Net earnings / employee   767 614 923 901 671 547 0 0